BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24006305)

  • 1. HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions.
    Juengel E; Meyer dos Santos S; Schneider T; Makarevic J; Hudak L; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1297-304. PubMed ID: 24006305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.
    Vallo S; Xi W; Hudak L; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
    Anticancer Drugs; 2011 Nov; 22(10):1002-9. PubMed ID: 21822119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
    Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
    Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
    Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
    Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of beta1 integrins in renal carcinoma cell lines exposed to the differentiation inducer valproic acid.
    Oertl A; Relja B; Makarevic J; Weich E; Höfler S; Jones J; Jonas D; Bratzke H; Baer PC; Blaheta RA
    Int J Mol Med; 2006 Aug; 18(2):347-54. PubMed ID: 16820945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.
    Juengel E; Engler J; Mickuckyte A; Jones J; Hudak L; Jonas D; Blaheta RA
    BJU Int; 2010 Feb; 105(4):549-57. PubMed ID: 19594733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
    Wedel S; Hudak L; Seibel JM; Juengel E; Oppermann E; Haferkamp A; Blaheta RA
    Prostate; 2011 May; 71(7):722-35. PubMed ID: 20954195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
    Makarević J; Rutz J; Juengel E; Kaulfuss S; Tsaur I; Nelson K; Pfitzenmaier J; Haferkamp A; Blaheta RA
    PLoS One; 2014; 9(10):e110244. PubMed ID: 25333694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism.
    Mani J; Fleger J; Rutz J; Maxeiner S; Bernd A; Kippenberger S; Zöller N; Chun FK; Relja B; Juengel E; Blaheta RA
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10564-10574. PubMed ID: 31841214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
    Laidler P; Gil D; Pituch-Noworolska A; Ciołczyk D; Ksiazek D; Przybyło M; Lityńska A
    Acta Biochim Pol; 2000; 47(4):1159-70. PubMed ID: 11996105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.
    Tsaur I; Hudak L; Makarević J; Juengel E; Mani J; Borgmann H; Gust KM; Schilling D; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
    J Cell Mol Med; 2015 Aug; 19(8):1795-804. PubMed ID: 25808196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells.
    Chen CL; Sung J; Cohen M; Chowdhury WH; Sachs MD; Li Y; Lakshmanan Y; Yung BY; Lupold SE; Rodriguez R
    J Pharmacol Exp Ther; 2006 Nov; 319(2):533-42. PubMed ID: 16868035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-polyunsaturated fatty acids stimulate beta1 integrin-mediated adhesion of human breast carcinoma cells to type IV collagen by activating protein kinases C-epsilon and -mu.
    Palmantier R; George MD; Akiyama SK; Wolber FM; Olden K; Roberts JD
    Cancer Res; 2001 Mar; 61(6):2445-52. PubMed ID: 11289113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
    Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
    Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation.
    Pouliot N; Connolly LM; Moritz RL; Simpson RJ; Burgess AW
    Exp Cell Res; 2000 Dec; 261(2):360-71. PubMed ID: 11112342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
    Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
    Clin Exp Metastasis; 2011 Jun; 28(5):479-91. PubMed ID: 21452015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
    Castro LM; Gallant M; Niles LP
    J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism].
    Zhao L; Zhang ZH; Zhu CM
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):802-5. PubMed ID: 19176032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.